IBM Watson, Broad Institute team up on $50M cancer drug resistance project Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, November 10, 2016

IBM Watson, Broad Institute team up on $50M cancer drug resistance project



Biotech
 Nov 10, 2016
 IBM Watson is kicking off another oncology partnership, this time with the Broad Institute of MIT and Harvard University. The $50 million tie-up will have the pair examining genome data from 10,000 drug-resistant tumors and cell line studies, with the goal of understanding the drivers behind cancer drug resistance and developing new treatments.....

 Unlike earlier studies, this project will have a broad focus rather than pinpoint a specific cancer,

0 comments :

Post a Comment

Your comments?